Periodontitis-induced systemic inflammation exacerbates atherosclerosis partly via endothelial–mesenchymal transition in mice

Abstract

Growing evidence suggests close associations between periodontitis and atherosclerosis. To further understand the pathological relationships of these associations, we developed periodontitis with ligature placement around maxillary molars or ligature placement in conjunction with Porphyromonas gingivalis lipopolysaccharide injection at the ligature sites (ligature/P.g. LPS) in Apolipoprotein E knock out mice and studied the atherogenesis process in these animals. The mice were fed with high fat diet for 11 weeks and sacrificed for analyzing periodontitis, systemic inflammation, and atherosclerosis. Controls did not develop periodontitis or systemic inflammation and had minimal lipid deposition in the aortas, but mice receiving ligature or ligature/P.g. LPS showed severe periodontitis, systemic inflammation, and aortic plaque formation. The aortic plaque contained abundant macrophages and cells expressing both endothelial and mesenchymal cell markers. The severity of periodontitis was slightly higher in mice receiving ligature/P.g. LPS than ligature alone, and the magnitude of systemic inflammation and aortic plaque formation were also notably greater in the mice with ligature/P.g. LPS. These observations indicate that the development of atherosclerosis is due to systemic inflammation caused by severe periodontitis. In vitro, P.g. LPS enhanced the secretion of pro-inflammatory cytokines from macrophages and increased the adhesion of monocytes to endothelial cells by upregulating the expression of adhesion molecules from endothelial cells. Moreover, secretory proteins, such as TNF-α, from macrophages induced endothelial–mesenchymal transitions of the endothelial cells. Taken together, systemic inflammation induced by severe periodontitis might exacerbate atherosclerosis via, in part, causing aberrant functions of vascular endothelial cells and the activation of macrophages in mice.

References

[1] Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol., 2015, 15: 30-44.

[2] Behle JH, . Heterogeneity of systemic inflammatory responses to periodontal therapy. J. Clin. Periodontol., 2009, 36: 287-294.

[3] Lundberg K, Wegner N, Yucel-Lindberg T, Venables PJ. Periodontitis in RA—the citrullinated enolase connection. Nat. Rev. Rheumatol., 2010, 6: 727-730.

[4] Yamanishi T, . Alpha2-adrenoceptors coordinate swallowing and respiration. J. Dent. Res., 2010, 89: 258-263.

[5] Zadik Y, Bechor R, Galor S, Levin L. Periodontal disease might be associated even with impaired fasting glucose. Br. Dent. J., 2010, 208: E20.

[6] Tan KH, . Porphyromonas gingivalis and Treponema denticola exhibit metabolic symbioses. PLoS Pathog., 2014, 10

[7] Chugh SS. Early identification of risk factors for sudden cardiac death. Nat. Rev. Cardiol., 2010, 7: 318-326.

[8] Holmlund A, Lampa E, Lind L. Oral health and cardiovascular disease risk in a cohort of periodontitis patients. Atherosclerosis, 2017, 262: 101-106.

[9] Bahekar AA, Singh S, Saha S, Molnar J, Arora R. The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am. Heart J., 2007, 154: 830-837.

[10] Kebschull M, Demmer RT, Papapanou PN. “Gum bug, leave my heart alone!”—epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. J. Dent. Res., 2010, 89: 879-902.

[11] Mochari H, Grbic JT, Mosca L. Usefulness of self-reported periodontal disease to identify individuals with elevated inflammatory markers at risk of cardiovascular disease. Am. J. Cardiol., 2008, 102: 1509-1513.

[12] Kurihara N, . Oral bacteria are a possible risk factor for valvular incompetence in primary varicose veins. Eur. J. Vasc. Endovasc. Surg., 2007, 34: 102-106.

[13] Chhibber-Goel J, . Linkages between oral commensal bacteria and atherosclerotic plaques in coronary artery disease patients. NPJ Biofilms Microbiomes, 2016, 2

[14] Lalla E, . Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol., 2003, 23: 1405-1411.

[15] Cui D, Li H, Lei L, Chen C, Yan F. Nonsurgical periodontal treatment reduced aortic inflammation in ApoE(−/−) mice with periodontitis. +, 2016, 5

[16] Chen PY, . Endothelial-to-mesenchymal transition drives atherosclerosis progression. J. Clin. Invest., 2015, 125: 4514-4528.

[17] Li A, . Endothelial-to-mesenchymal transition: a potential mechanism for atherosclerosis plaque progression and destabilization. DNA Cell Biol., 2017, 36: 883-891.

[18] Jackson AO, Zhang J, Jiang Z, Yin K. Endothelial-to-mesenchymal transition: a novel therapeutic target for cardiovascular diseases. Trends Cardiovasc. Med., 2017, 27: 383-393.

[19] Lu CC, . Developmental pathways and endothelial to mesenchymal transition in canine myxomatous mitral valve disease. Vet. J., 2015, 206: 377-384.

[20] Jimenez SA, Piera-Velazquez S. Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of systemic sclerosis-associated pulmonary fibrosis and pulmonary arterial hypertension. Myth or reality?. Matrix Biol., 2016, 51: 26-36.

[21] Song S, . The role of PDGF-B/TGF-beta1/neprilysin network in regulating endothelial-to-mesenchymal transition in pulmonary artery remodeling. Cell. Signal., 2016, 28: 1489-1501.

[22] Good RB, . Endothelial to mesenchymal transition contributes to endothelial dysfunction in pulmonary arterial hypertension. Am. J. Pathol., 2015, 185: 1850-1858.

[23] Yan Z, . Rab11a mediates vascular endothelial-cadherin recycling and controls endothelial barrier function. Arterioscler. Thromb. Vasc. Biol., 2016, 36: 339-349.

[24] Evrard SM, . Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat. Commun., 2016, 7

[25] Hayashi C, Gudino CV, Gibson FC 3rd, Genco CA. Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways. Mol. Oral Microbiol., 2010, 25: 305-316.

[26] Moore KJ, Sheedy FJ, Fisher EA. Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol., 2013, 13: 709-721.

[27] Graves DT, Fine D, Teng YT, Van Dyke TE, Hajishengallis G. The use of rodent models to investigate host–bacteria interactions related to periodontal diseases. J. Clin. Periodontol., 2008, 35: 89-105.

[28] Rovin S, Costich ER, Gordon HA. The influence of bacteria and irritation in the initiation of periodontal disease in germfree and conventional rats. J. Periodontal Res., 1966, 1: 193-204.

[29] Nowotny A, Sanavi F. Induction of nonspecific tolerance to endotoxins reduces the alveolar bone resorption in ligature-treated rats. Infect. Immun., 1983, 39: 873-878.

[30] Getz GS, Reardon CA. Animal models of atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 2012, 32: 1104-1115.

[31] Huang JH, Lin YY, Lai YY, Hu SW. Lethal outcome caused by Porphyromonas gingivalis A7436 in a mouse chamber model is associated with elevated titers of host serum interferon-gamma. Oral Microbiol. Immunol., 2006, 21: 100-106.

[32] Hiyari S, . Heritability of periodontal bone loss in mice. J. Periodontal Res., 2015, 50: 730-736.

[33] Liu R, Desta T, Raptis M, Darveau RP, Graves DT. P. gingivalis and E. coli lipopolysaccharides exhibit different systemic but similar local induction of inflammatory markers. J. Periodontol., 2008, 79: 1241-1247.

[34] Kim T, . Removal of pre-existing periodontal inflammatory condition before tooth extraction ameliorates medication-related osteonecrosis of the jaw-like lesion in mice. Am. J. Pathol., 2018, 188: 2318-2327.

[35] Hassan M. CANTOS: a breakthrough that proves the inflammatory hypothesis of atherosclerosis. Glob. Cardiol. Sci. Pract., 2018, 2018: 2.

[36] Ridker PM, . Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med., 2017, 377: 1119-1131.

[37] Mahler GJ, Farrar EJ, Butcher JT. Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells. Arterioscler. Thromb. Vasc. Biol., 2013, 33: 121-130.

[38] Wang Z, . Role of endothelial-to-mesenchymal transition induced by TGF-beta1 in transplant kidney interstitial fibrosis. J. Cell. Mol. Med., 2017, 21: 2359-2369.

[39] Medici D, Potenta S, Kalluri R. Transforming growth factor-beta2 promotes Snail-mediated endothelial–mesenchymal transition through convergence of Smad-dependent and Smad-independent signalling. Biochem. J., 2011, 437: 515-520.

[40] Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature, 2011, 473: 317-325.

[41] Yang Y, . Macrophage-derived foam cells impair endothelial barrier function by inducing endothelial–mesenchymal transition via CCL-4. Int. J. Mol. Med., 2017, 40: 558-568.

[42] Maekawa T, . Chronic oral infection with Porphyromonas gingivalis accelerates atheroma formation by shifting the lipid profile. PLoS ONE, 2011, 6

[43] Huang Q, . AIP1 suppresses atherosclerosis by limiting hyperlipidemia-induced inflammation and vascular endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol., 2013, 33: 795-804.

[44] Daugherty A, . The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E−/− mice. J. Clin. Invest., 1997, 100: 1575-1580.

Funding

UCLA Chancellor's Office

U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR)(DE023348)